Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: Evaluation of the bleeding risk

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 4 SUPPL. 1, 2000, Pages

  Manzano, M L ^a   Arocena, C ^a   Tomas J F ^b   Hedner, U ^a   Quiroga, J A ^a   Carreño, Vincente ^a,c  

^a Department of Hepatology ^*

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c s n   (Spain)

Author keywords

Bleeding risk; Chronic liver disease; Factor VII:C; Liver cirrhosis; Prothrombin activity

Indexed keywords

BLOOD CLOTTING FACTOR 7; PROTHROMBIN;

ADULT; AGED; BLEEDING; BLEEDING TIME; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 0034043967     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200004001-00018     Document Type: Conference Paper

References (14)

1. Mammem EF. Coagulation defects in liver disease. Med Clin North Am 1994; 78: 545-554.
2. Paramo AJ, Rochae E. Hemostasis in advanced liver disease. Sem Thromb Hemost 1993; 19: 184-190.
3. Green G, Poller L, Thomson JM, Dymock IW. Factor VII as a marker of hepatocellular synthetic function in liver disease. J Clin Pathol 1976; 29: 971-975.
4. Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis 1998; 9 (suppl 1): 147-152.
5. Mielke CH. Measurement of the bleeding time. Thromb Haemost 1984; 52: 210-211.
6. Chopra S, Griffin PH. Laboratory test and diagnostic procedures in evaluation of liver disease. Am J Med 1985; 79: 221-230.
7. Izumi S, Langley PG, Wendon J, Ellis AJ, Pernambuco RB, Hughes RD, Williams R. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 1996; 23: 1507-1511.
8. Orlando M, Casalbore P, Camagna A, Lauro R, Tardella L, Hassan HJ. Factor VII in liver cirrhosis. Haemostasis 1982; 11: 73-78.
9. Hoffman M, Monroe DM, Oliver JA, Roberts HR. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995; 86: 1794-1801.
10. Violi F, Ferro D, Basili S, Cimminiello C, Saliola M, Vezza E, Cordova C. Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. Hepatology 1995; 22: 96-100.
11. Hedner U, Glazer S, Falch J. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. Transfus Med Rev 1993; 2: 78-83.
12. Lusher J, Ingerslev J, Roberts H, Hedner U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis 1998; 9 (suppl 1): 111-114.
13. Bernstein DE, Jeffers L, Erhardtsen E, Reddy KR, Glazer S, Squiban P, et al. Recombinant factor Vila corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 1997; 113: 1930-1937.
14. Kristensen J, Killander A, Hippe E, Helleberg C, Ellegård J, Holm M, et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26: 159-164.